Most regular investors haven’t heard of a guy named Jim Breyer. But Silicon Valley insiders know him as one of the most powerful venture capitalists around.
Back in 2005, his venture capital firm Accel Partners plunked down $12.2 million for a stake in a little-known startup run by a college dropout by the name of Mark Zuckerberg — a name I’m sure you’re familiar with.
By the time May 18, 2012 came around, both men made an absolute mint. That’s the day Facebook (Nasdaq: FB) went public, allowing early financial backers a way to put a dollar value....More>>>
Marathon Digital Holdings Inc. (NASDAQ:MARA) shares were trading lower Tuesday after the cryptocurrency market dropped lower. Ethereum (CRYPTO: ETH) and Bitcoin (CRYPTO: BTC) led the market, both dropping lower by a significant percentage.
Marathon Digital was down 9.05% at $39.48 at last check Tuesday afternoon.
Marathon Digital Daily Chart Analysis
Shares look to have broken out of what technical traders call a pennant pattern and are cooling off, possibly beginning to consolidate. The price was condensed in the pattern until it broke out and pushed higher, now possibly....More>>>
One day many years ago, I found myself stuck in traffic and noticed a peculiar sign. It said something about the construction that was going on — the very thing that was hampering my commute.
It said all this construction was being funded by a bond. This was before I had ever started my career in finance, so bonds were an unfamiliar thing. But when I began my investment career, I soon realized that I could actually invest in these things. And the more I learned, the more I was ecstatic.
After all, If you can’t beat ’em, might as well make money off them…
There’s a lot of anger out there.
Anger directed at multinational corporations. Anger at politicians who betray their campaign promises. Anger at global elites with billions in the bank.
Rising popular discontent will be on the agenda this week as the world’s richest and most powerful people make their annual pilgrimage to Davos for the World Economic Forum.
This year, the principles long promoted by conference participants — globalization, free trade, working together to solve problems — face a multitude of threats. Brexit looms, and so does....More>>>
Shares of Nektar Therapeutics (NASDAQ:NKTR), a biopharmaceutical company that utilizes its proprietary intellectual property via licensing deals and through collaborations in the clinical development process to help fight cancer, autoimmune diseases, and chronic pain, surged as much as 20% on Thursday after the company reported its fourth-quarter and full-year results after the closing bell on Wednesday.
For the quarter, Nektar wound up reporting sales of $37.5 million, a decline of 5% from the prior-year period. For the year, sales fell to $165.4....More>>>